These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 26537928

  • 1. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis.
    Erkan E, Zhao X, Setchell K, Devarajan P.
    Pediatr Nephrol; 2016 Apr; 31(4):581-8. PubMed ID: 26537928
    [Abstract] [Full Text] [Related]

  • 2. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
    Pérez V, López D, Boixadera E, Ibernón M, Espinal A, Bonet J, Romero R.
    BMC Nephrol; 2017 Feb 03; 18(1):49. PubMed ID: 28158993
    [Abstract] [Full Text] [Related]

  • 3. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
    Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS.
    Eur J Clin Invest; 2015 Apr 03; 45(4):394-404. PubMed ID: 25682967
    [Abstract] [Full Text] [Related]

  • 4. Urinary fibrinogen and renal tubulointerstitial fibrinogen deposition: Discriminating between primary FSGS and minimal change disease.
    Wang Y, Zheng C, Xu F, Liu Z.
    Biochem Biophys Res Commun; 2016 Sep 23; 478(3):1147-52. PubMed ID: 27539323
    [Abstract] [Full Text] [Related]

  • 5. Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children.
    Huang Z, Zhang Y, Zhou J, Zhang Y.
    Biomed Res Int; 2017 Sep 23; 2017():7298160. PubMed ID: 28246603
    [Abstract] [Full Text] [Related]

  • 6. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
    Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
    Kidney Int; 2010 Aug 23; 78(3):296-302. PubMed ID: 20485332
    [Abstract] [Full Text] [Related]

  • 7. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
    Pediatr Nephrol; 2014 Aug 23; 29(8):1363-71. PubMed ID: 24263531
    [Abstract] [Full Text] [Related]

  • 8. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM, Ezzat DA, Doudar NA, Adel M.
    Iran J Kidney Dis; 2018 Mar 23; 12(2):107-111. PubMed ID: 29507273
    [Abstract] [Full Text] [Related]

  • 9. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
    An JN, Hyeon JS, Jung Y, Choi YW, Kim JH, Yang SH, Oh S, Kwon S, Lee SH, Cho JH, Park SH, Ha H, Kim DK, Lee JP, Hwang GS.
    Sci Rep; 2019 Oct 11; 9(1):14707. PubMed ID: 31605028
    [Abstract] [Full Text] [Related]

  • 10. Clinical Significance of Urinary Biomarkers in Patients With Primary Focal Segmental Glomerulosclerosis.
    Zhang Q, Jiang C, Tang T, Wang H, Xia Y, Shao Q, Zhang M.
    Am J Med Sci; 2018 Apr 11; 355(4):314-321. PubMed ID: 29661344
    [Abstract] [Full Text] [Related]

  • 11. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis].
    Li YH, Huang HC, Liu G, Zhang YK.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr 11; 36(2):135-8. PubMed ID: 15100729
    [Abstract] [Full Text] [Related]

  • 12. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2016 Mar 01; 310(5):F335-41. PubMed ID: 26697986
    [Abstract] [Full Text] [Related]

  • 13. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
    Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K.
    Sci Rep; 2018 Nov 23; 8(1):17322. PubMed ID: 30470792
    [Abstract] [Full Text] [Related]

  • 14. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis.
    Shui HA, Huang TH, Ka SM, Chen PH, Lin YF, Chen A.
    Nephrol Dial Transplant; 2008 Jan 23; 23(1):176-85. PubMed ID: 17881425
    [Abstract] [Full Text] [Related]

  • 15. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
    Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ.
    Pediatr Nephrol; 2015 Mar 23; 30(3):469-77. PubMed ID: 25239302
    [Abstract] [Full Text] [Related]

  • 16. The application of electron microscopic morphometry as helpful method in the diagnosis of focal segmental glomerulosclerosis (FSGS) early phase. I. Morphometric electron microscopic studies of renal glomeruli in cases of focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD) and mesangioproliferative glomerulonephritis (GNMES) in children.
    Woźniak A, Salwa-Zurawska W, Kaczmarek E, Bortkiewicz E, Gładysz J, Maciejewski J.
    Pol J Pathol; 2001 Mar 23; 52(1-2):27-36. PubMed ID: 11505678
    [Abstract] [Full Text] [Related]

  • 17. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
    Voznesenskaia TS, Sergeeva TV.
    Ter Arkh; 2002 Mar 23; 74(6):31-3. PubMed ID: 12136479
    [Abstract] [Full Text] [Related]

  • 18. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
    Nezhad ST, Momeni B, Basiratnia M.
    Saudi J Kidney Dis Transpl; 2010 Sep 23; 21(5):886-91. PubMed ID: 20814126
    [Abstract] [Full Text] [Related]

  • 19. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
    Pérez V, Ibernón M, López D, Pastor MC, Navarro M, Navarro-Muñoz M, Bonet J, Romero R.
    PLoS One; 2014 Sep 23; 9(1):e87731. PubMed ID: 24498182
    [Abstract] [Full Text] [Related]

  • 20. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients.
    Navarro-Muñoz M, Ibernon M, Pérez V, Ara J, Espinal A, López D, Bonet J, Romero R.
    Nephrol Dial Transplant; 2011 Dec 23; 26(12):3914-23. PubMed ID: 21414970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.